2003
DOI: 10.1016/j.addr.2003.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Collagen gel systems for sustained delivery and tissue engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
351
0
3

Year Published

2010
2010
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 462 publications
(358 citation statements)
references
References 61 publications
4
351
0
3
Order By: Relevance
“…Gels, such as collagen type I [3,4] and platelet-rich plasma [5], have been investigated but their use is currently limited due to issues with purity and regulatory standards (such as the FDA and MHRA), and their inherent weak mechanical properties that are essential for this type of tissue. Electrospun fibre scaffolds are finding increasing use…”
Section: Introductionmentioning
confidence: 99%
“…Gels, such as collagen type I [3,4] and platelet-rich plasma [5], have been investigated but their use is currently limited due to issues with purity and regulatory standards (such as the FDA and MHRA), and their inherent weak mechanical properties that are essential for this type of tissue. Electrospun fibre scaffolds are finding increasing use…”
Section: Introductionmentioning
confidence: 99%
“…SIS suspensions are not covalent and not cross-linked. Alternatively, SIS in an injected tissue body can have viscous properties through entanglements through hydrophobic and electrostatic interactions of collagenous fibers (Wallace and Rosenblatt, 2003). This behavior is advantageous for injectable delivery, since the SIS suspension can be easily fluidized at room temperature, but become relatively rigid at body temperature.…”
Section: Discussionmentioning
confidence: 99%
“…Various injectable drug depots, like those using collagen, gelatin, hyaluronate, cellulose, and fibrin, as well as synthetic materials, have been developed for this purpose (Kim et al, 2011;Kang et al, 2010;Lee et al, 2010;Yang et al, 2009;Yu and Ding, 2008;Lupton and Alster, 2000). Among them, collagen has the advantage of mimicking many features of the extracellular matrix (ECM) of mammals and it has high mechanical strength, good biocompatibility, low antigenicity, and water-uptake properties (Bhang et al, 2009;Kim et al, 2009;Ruozi et al, 2009;Pollack, 1999;Wallace and Rosenblatt, 2003). In addition, collagens easily flow in biological mediums, suggesting the possibility of it acting as an easily injectable drug depot (Wallace and Rosenblatt, 2003).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…TGF-β3 is a type of protein produced by almost all types of cells (Schwartz et al, 1993) ant it is soluble in an acidic environment as well as water resulting in a sticky jelly (Wallace and Rosenblatt, 2003) and, thus, it is not appropriate to dissolve it in water and instead aliquot in an micro-litre tube with the final solution less than 1ml.…”
Section: Solventmentioning
confidence: 99%